Startups

Associate Director, Human Resources

Repertoire Immune Medicines · Remote (US) · Remote

← All jobs
About Repertoire Immune Medicines

Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease. Backed by SoftBank VF.

About the role

Repertoire Immune Medicines is a clinical-stage biotechnology company harnessing the power of the human immune system to develop transformative therapies for cancer and autoimmune disease. Using its proprietary DECODE™ platform — which maps the immune synapse between T cell receptors (TCRs) and their antigen targets — Repertoire translates unique biological insights into potent and targeted off-the-shelf immune medicines.

What they're looking for

  • 8+ years of progressive HR experience, including substantive HR Operations and business partnership experience, biotech or life sciences industry experience strongly preferred
  • Strong knowledge of federal and state employment laws and ERISA regulations, Swiss or European HR experience preferred
  • Advanced proficiency in HRIS platforms (ADP preferred) and Microsoft Excel (PivotTables, XLOOKUP, data analysis, reporting)
  • Sound judgment on confidential and sensitive matters, high standard of discretion and documentation
  • Strong analytical, problem-solving, communication, and stakeholder management skills
More about this role

Repertoire Immune Medicines is a clinical-stage biotechnology company harnessing the power of the human immune system to develop transformative therapies for cancer and autoimmune disease. Using its proprietary DECODE™ platform — which maps the immune synapse between T cell receptors (TCRs) and their antigen targets — Repertoire translates unique biological insights into potent and targeted off-the-shelf immune medicines. The company integrates deep protein engineering expertise with artificial intelligence, powered by a proprietary DECODE database of over one billion TCR-antigen interactions, to accelerate discovery and optimize drug candidates.

From its sites in Watertown, Massachusetts and Zurich, Switzerland, Repertoire is advancing a pipeline of T cell-targeted immunotherapies with the potential to address a broad range of cancers and autoimmune disorders. The company's lead oncology program, RPTR-1-201, a TCR bispecific, has initiated a Phase 1/2 clinical trial across multiple solid tumor indications. Repertoire plans to advance additional TCR bispecific therapies into clinical trials over the next 12-18 months. In autoimmune disease, Repertoire is partnering with leading...

Read the full posting on Repertoire Immune Medicines's site ↗

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.